Skip to main content
. 2022 Jul 28;12:12899. doi: 10.1038/s41598-022-17088-0

Figure 3.

Figure 3

EGCG inhibits CoV attachment to cells. (a) Time-of-addition assay showing pre-treatment (pre), post-treatment (post) or simultaneous (sim) treatment of cells. (b) Pre-treatment of cells, or treatment of cells post-infection with HCoV-229E or HCoV-OC43, does not inhibit infection to similar extents as virion pre-treatment. Mean values with standard deviation of three independent experiments are plotted. (c) HCoV-OC43 virions were pre-treated with EGCG or heparin for 10 min at 37 °C then cooled on ice and added to pre-chilled Huh7 for 1 h on ice. (d) VSV-SARS-CoV-2 were pre-treated as described above and added to pre-chilled Huh7 or Calu-3 cells. Attached virions were quantified by RT-qPCR after washing cells with phosphate buffered saline (PBS) three times. Mean values with standard deviation from qPCR triplicates of two independent experiments are plotted. Statistical significance was assessed by Welch’s t test (***p < 0.001, ****p < 0.0001).